India’s First Lung Cancer Treatment Guidelines

Guideline Title: Lung Cancer Treatment and Palliation Guidelines
Release Date: 9 February 2026
Announced By: Union Health Minister
Developed By: Department of Health Research (DHR) and Directorate General of Health Services (DGHS) in collaboration with leading oncology experts
Number of Recommendations: 15 evidence‑based recommendations covering diagnosis, treatment pathways and palliative care
Core Focus Areas:
Early diagnosis and screening of high‑risk populations
Standardised treatment protocols for public and private sectors
Strengthened palliative care services
Alignment: Released on the occasion of World Cancer Day

Lung cancer remains the leading cause of cancer‑related mortality globally and in India, accounting for a substantial share of the cancer burden.
Prior to 2026, India lacked a unified, nationally endorsed protocol, leading to wide variations in clinical practice across states and between public‑private providers.
The guidelines were formulated through systematic evidence synthesis, adapting international best practices to Indian healthcare realities, including resource constraints and accessibility issues.

Standardisation: Provides a uniform framework, reducing disparities in care quality and outcomes.
Early Detection: Emphasises screening high‑risk groups (e.g., long‑term smokers, occupational exposure), potentially lowering mortality through timely intervention.
Health System Strengthening: Aligns with the National Health Policy 2017 and the Ayushman Bharat initiative by integrating cancer care into primary health services and expanding palliative care.
Economic Impact: Early diagnosis and standardized treatment can reduce treatment costs and productivity losses associated with advanced‑stage lung cancer.
Policy Integration: Sets a precedent for developing disease‑specific, evidence‑based guidelines for other non‑communicable diseases (NCDs).

Article 21 (Right to Life & Health): The guidelines support the state's obligation to protect health as part of the right to life.
National Health Policy 2017: Calls for evidence‑based interventions and strengthening of NCD management, which these guidelines directly address.
Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (PMJAY): The standardised protocols can be incorporated into the cashless treatment packages under PMJAY.